| Ytd | 68.28% | |
| 1y | 47.73% |
| Open | 4.79 | Prev Close | 4.84 | Low | 4.68 | High | 5.21 | Mkt Cap | 24.96M |
| Vol | 174.66K | Avg Vol | 2.35M | EPS | -2.76 | P/E | N/A | Forward P/E | -0.61 |
| Beta | 3.29 | Short Ratio | 2.41 | Inst. Own | 1.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.74 | 200-d Avg | 2.57 | 1yr Est | 13.50 |
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform
HeartSciences Inc. (HSCS) came out with a quarterly loss of $0.86 per share versus the Zacks Consens
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.86) per share. This is a 45.5
Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-
Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session
Fortitude purchased approximately $1,000,000 of HeartSciences' shares of common stock at $2.43 per s
Fortitude Mining Holdings, Inc. ("Fortitude" or the âCompanyâ), a vertically-integrated digital
Company believes proposed Fortitude Mining Holdings business combination represents a significant va
With 12 MW of power capacity now delivered, Fortitude has completed construction, brought the facili
Gainers Gossamer Bio (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market sess
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.87) per share which missed th
Company believes proposed Fortitude merger represents a significant opportunity for the Company's sh
Gainers Aditxt (NASDAQ:ADTX) shares increased by 151.6% to $0.05 during Tuesday's regular sessi
Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market sessi
Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining
FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integra
Patent covers machine-learning models that use ECG data to estimate echocardiogram parameters indica
HeartSciences Inc. (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), a heal
Bunkerhill Health's FDA-cleared ECG-EF algorithm for the detection of reduced ejection fraction beco
Agreement follows Cibolo Health's endorsement of MyoVista Insights for its network of 127 independen
HeartSciences Inc. (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), a heal
Agreement with St. Vincent Health marks HeartSciences' transition from early adopter installations t
Rennova Health (OTCMKTS:RNVA - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) a
Southlake, TX, April 14, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSc
10x Genomics (NASDAQ: TXG - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are
HeartSciences (NASDAQ: HSCS - Get Free Report) and Hinge Health (NYSE: HNGE - Get Free Report) are b
Southlake, TX , March 25, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“Hear
Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“Heart
Analysts change ratings & price targets for HSCS, ONDS, STRO, PFE, HST, CABA, INSM, PVH. See ful
Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.63) per share which beat the
Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“He
Southlake, TX, Feb. 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“Heart
Southlake, TX, Jan. 29, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartS
Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and raises
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.85) per share which beat the
Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers
HeartSciences Inc. (NASDAQ:HSCS) reported quarterly losses of $(1.58) per share which beat the analy
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(1.86) per share which beat the